Capital Research Global Investors Holds 51.3M GE HealthCare Shares

Ticker: GEHC · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, healthcare, passive-investing

TL;DR

**Big investor Capital Research Global Investors owns 51.3M shares of GE HealthCare.**

AI Summary

Capital Research Global Investors, a Delaware-based investment firm, filed an amended SC 13G/A on February 9, 2024, disclosing its beneficial ownership in GE HealthCare Technologies Inc. As of December 29, 2023, the firm holds sole voting power over 51,341,628 shares of common stock. This filing indicates a significant institutional stake, which can provide stability but also means large block trades could impact share price.

Why It Matters

This filing reveals a major institutional investor's substantial stake in GE HealthCare, signaling their confidence in the company but also highlighting potential market impact from any future changes in their position.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of a significant institutional holding, not indicating any immediate negative risk.

Analyst Insight

Investors should note the substantial institutional ownership by Capital Research Global Investors, as large positions can influence stock stability and liquidity. Monitor future 13G/A filings for any significant changes in their holdings, which could signal a shift in institutional sentiment.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

Who is the reporting person in this SC 13G/A filing?

The reporting person is Capital Research Global Investors, as stated in item 1 of the cover page and the 'FILED BY' section.

What is the subject company whose shares are being reported?

The subject company is GE HealthCare Technologies Inc., as indicated in the 'SUBJECT COMPANY' section and the 'Name of Issuer' on the cover page.

How many shares does Capital Research Global Investors have sole voting power over?

Capital Research Global Investors has sole voting power over 51,341,628 shares, as reported in item 5 of the cover page.

What was the 'Date of Event Which Requires Filing of this Statement'?

The date of the event which required the filing of this statement was December 29, 2023, as specified on the cover page.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(b), as indicated by the checked box on the cover page.

From the Filing

0001422848-24-000041.txt : 20240209 0001422848-24-000041.hdr.sgml : 20240209 20240209174632 ACCESSION NUMBER: 0001422848-24-000041 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-93934 FILM NUMBER: 24616429 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Capital Research Global Investors CENTRAL INDEX KEY: 0001422848 ORGANIZATION NAME: IRS NUMBER: 951411037 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 SOUTH HOPE STREET STREET 2: 55TH FL CITY: LOS ANGELES STATE: CA ZIP: 90071 SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 ) * GE HealthCare Technologies Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 36266G107 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 36266G107 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors 95-1411037 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 51,341,628 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 51,344,719 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 51,344,719 Beneficial ownership disclaimed pursuant to Rule 13d-4 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.3% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer GE HealthCare Technologies Inc. (b) Address of Issuer's Principal Executive Offices 500 WEST MONROE STREET, CHICAGO, IL 60661 Item 2. (a) Name of Person Filing Capital Research Global Investors (b) Address of Principal Business Office or, if None, Residence 333 South Hope Street, 55th Fl, Los Angeles, CA 90071 (c) Citizenship N/A (d) Title of Class of Securities Common Stock (e) CUSIP Number 36266G107 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78

View on Read The Filing